About
Ailsa Dalgliesh is Head of Capital Formation & Platform at Palo Santo, where her work spans company creation, operational strategy, investor relations, and portfolio management. She holds a Ph.D. and has worked across R&D, clinical, operations, finance, legal, and communications functions. She has contributed to raising over $1.9B in institutional capital across private and public funds, as well as $175M for an early-stage biotech.
Experience
- Palo SantoHead of Capital Formation & Platformcurrent2026 — presentPalo Alto, California, United States
- Granum ScientificPrincipal Consultantcurrent2026 — present
- Frazier Life SciencesHead of Investor Relations2023 — 2026Menlo Park, California, United States
- Affini-T TherapeuticsDirector of Investor Relations and Corporate Communications2021 — 2023Seattle, Washington, United States
- Affini-T TherapeuticsDirector Of Operations2021
- Fred HutchBusiness Development Manager within Partnerships and Alliances2018 — 2021Greater Seattle Area
- Keon Research LLCInnovation Consultant2018Seattle, Washington
- Mayo Clinic Graduate School of Biomedical SciencesPredoctoral Scholar2016 — 2018Rochester, Minnesota Area
- University of California, DavisPh.D. Graduate Researcher2013 — 2018
- University of California, DavisGraduate Student2013 — 2018
- University of California, DavisTeaching Assistant - Electrophysiology2014 — 2015Davis, CA
Skills & more
StrategyPublic Speaking2Management2LeadershipNegotiationBusiness Development2Cell Therapy2Gene Therapy2Immunology1Biomedical Engineering1Intellectual Property1Life Sciences1
+12 more
Data AnalysisBiotechnologyCell CulturePCRMolecular BiologyBiochemistryMicroscopyGel ElectrophoresisStatisticsImmunohistochemistryHigh-Performance Liquid Chromatography (HPLC)Liquid Chromatography-Mass Spectrometry (LC-MS)- Graduate Teaching Assistant — University of California, Davis
- Strengths Based Leadership Training — University of California, Davis
From Ailsa's professional profile.
Colleagues at Palo Santo VC
Adrienne Jo
Investor at Palo Santo VC
Charles Nichols
Investor at Palo Santo VC
Daniel Goldberg
Founder at Bridge Venture Fund
Edny Inui
Investor at Palo Santo VC
Gretchen Temeles
Investor at Palo Santo VC
Ingrid Vergara
Investor at Palo Santo VC
Jason Thomas
Partner at Bridge Venture Fund
John D. McCorvy
Investor at Palo Santo VC
Frequently asked questions
- Who is Ailsa Dalgliesh?
- Ailsa Dalgliesh is Head of Capital Formation & Platform at Palo Santo, where her work spans company creation, operational strategy, investor relations, and portfolio management. She holds a Ph.D. and has worked across R&D, clinical, operations, finance, legal, and communications functions. She has contributed to raising over $1.9B in institutional capital across private and public funds, as well as $175M for an early-stage biotech.
- Where does Ailsa Dalgliesh work?
- Ailsa Dalgliesh is Principal at Palo Santo VC.
- Where did Ailsa Dalgliesh go to school?
- Ailsa Dalgliesh studied at Mayo Clinic Graduate School of Biomedical Sciences (Pre-Doctoral Scholar, Biomedical Engineering and Physiology); University of California, Davis (Doctor of Philosophy (Ph.D.), Molecular); University of California, Davis (Bachelor of Science (B.S.), Biological and Biomedical Sciences).
Same school
Also attended University of California, Davis154
Charles CallSLP & Venture Partner at Cottonwood Technology FundDavid PhuController at Felicis VenturesBryan EglanDirector of Business Development at Menlo VenturesScott MaxwellInvestor at OpenView Venture PartnersMasoud AdinaHead of Compliance at GreycroftCraig MuirInvestor at Third Rock Ventures
+ 148 more
Shared employers
Also worked at Frazier Life Sciences49
Patrick HeronManaging Partner at Frazier Life SciencesDaniel EstesGeneral Partner at Frazier Life SciencesJames W. BrushGeneral Partner and Portfolio Manager at Frazier Life SciencesAnna H. ChenPartner at Frazier Life SciencesGordon EmpeyCOO, Partner and General Counsel at Frazier Life SciencesAlbert ChaManaging Partner at Frazier Life Sciences
+ 43 more
Also worked at Affini-T Therapeutics2
Also worked at Fred Hutch13
Luke RigganAssociate at Amplify PartnersMichael KalosInvestor at 82VSNida ShekhaniDeputy COO & Chief Strategy Officer at Oncology VenturesMark FleischauerPartner at FusionX VenturesJoris VanderlochtChief Scientific Director at Bioqube VenturesW. Michael GallatinSenior Advisor at Frazier Life Sciences
+ 7 more
Also worked at University of California, Davis43
Bryan EglanDirector of Business Development at Menlo VenturesScott MaxwellInvestor at OpenView Venture PartnersJosephine ChenInvestor at Sequoia CapitalCindy DoleDeputy General Counsel & Corporate Secretary at Samsung Catalyst FundGordon RausserAdvisory Board Member at Rembrandt Venture PartnersToni AlejandriaEvents + Community at Rackhouse Venture Management Lp
+ 37 more